1. Home
  2. PEN

PEN

Penumbra Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

Founded: 2004 Country:
United States
United States
Employees: N/A City: ALAMEDA
Market Cap: 7.8B IPO Year: 2015
Target Price: $298.55 AVG Volume (30 days): 337.2K
Analyst Decision: Strong Buy Number of Analysts: 11
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.32 EPS Growth: N/A
52 Week Low/High: $180.93 - $348.67 Next Earning Date: 05-07-2024
Revenue: $1,058,522,000 Revenue Growth: 24.95%
Revenue Growth (this year): 18.75% Revenue Growth (next year): 16.63%

Share on Social Networks: